FeesSafety
Pluang+

Trinity Capital to release Q3 2026 financial results on Nov 4 with a conference call.

Company Fundamentals
06 Oct 2026, 15:00 WIB
PRNewsWire
View Source
Neutral
Trinity Capital to release Q3 2026 financial results on Nov 4 with a conference call.

Trinity Capital Inc., an international alternative asset manager, announced it will release its third quarter 2026 financial results on November 4, 2026, at 8:00 a.m. ET. The company will hold a conference call at 12:00 p.m. ET the same day to discuss the results, accessible via phone and webcast. A replay of the call will be available for 90 days on the company's website. This update is important for investors tracking Trinity Capital's performance in private credit markets across various lending sectors.

Trinity Capital's upcoming third quarter 2026 financial results announcement provides context for financial sector market activity. For readers following financials, here is Pluang's market snapshot as of Oct 06, 2026 18:43 WIB: out of 85 priced Financials-sector US stocks tradable on Pluang, 70 rose and 10 fell today. Notable movers include ING Groep NV at USD 35.29 with a 1-day change of +1.50% and 100% buy order activity, Riot Platforms Inc at USD 19.60 with a 1-day change of +1.45% and 91% buy order activity, and Barclays PLC at USD 23.91 with a 1-day change of +1.36% but 100% sell order activity.

More News

NCH performs US first tricuspid valve repair with PASCAL Precision system after FDA approval

NCH performs US first tricuspid valve repair with PASCAL Precision system after FDA approval

Naples Comprehensive Health (NCH) has completed the first tricuspid valve repair in the US using the PASCAL Precision system following FDA approval. This minimally invasive catheter-based procedure offers a new treatment option for patients with seve...

Market News
Bullish
55 minutes ago
Immunocore to present Phase 1 data on brenetafusp and KIMMTRAK combo for metastatic uveal melanoma at SITC 2026

Immunocore to present Phase 1 data on brenetafusp and KIMMTRAK combo for metastatic uveal melanoma at SITC 2026

Immunocore Holdings will present Phase 1/2 clinical trial data for brenetafusp alone and combined with KIMMTRAK in treating metastatic uveal melanoma at the 2026 Society for Immunotherapy of Cancer meeting. This trial evaluates safety and efficacy in...

Company Fundamentals
Bullish
55 minutes ago
Collegium Pharmaceutical and Boston Legacy FC expand partnership to support neurodivergent youth in Massachusetts sports.

Collegium Pharmaceutical and Boston Legacy FC expand partnership to support neurodivergent youth in Massachusetts sports.

Collegium Pharmaceutical and Boston Legacy FC have extended their partnership to include youth coach training, an annual Sports for All Summit, and sensory inclusion programs aimed at supporting neurodivergent children, especially those with ADHD, in...

Others
Bullish
1 hour ago
Gilat Satellite Networks to attend Deutsche Bank Global Space and Defense Tech Summit in NYC

Gilat Satellite Networks to attend Deutsche Bank Global Space and Defense Tech Summit in NYC

Gilat Satellite Networks announced that its CEO Adi Sfadia and CFO Gil Benyamini will attend the Deutsche Bank Global Space and Defense Tech Summit on November 18, 2026, in New York City. The event will feature one-on-one and group meetings, providin...

Market News
Neutral
1 hour ago
Boralex buys Wind2 to boost UK wind energy projects by 350 MW, expanding its renewable footprint.

Boralex buys Wind2 to boost UK wind energy projects by 350 MW, expanding its renewable footprint.

Boralex Inc. has acquired Wind2, a UK-based renewable energy developer with about 350 MW of advanced wind projects across Scotland, England, and Wales. This acquisition strengthens Boralex's presence and capabilities in the UK, aligning with its stra...

Company Fundamentals
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App